首页> 美国卫生研究院文献>Emerging Infectious Diseases >HIV Hepatitis C and Hepatitis B Infections and Associated Risk Behavior in Injection Drug Users Kabul Afghanistan
【2h】

HIV Hepatitis C and Hepatitis B Infections and Associated Risk Behavior in Injection Drug Users Kabul Afghanistan

机译:阿富汗喀布尔的注射吸毒者中的HIV丙型肝炎和乙型肝炎感染及相关风险行为

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Limited prevalence data for HIV, hepatitis B surface antigen (HBsAg), and hepatitis C virus (HCV) exist for Afghanistan. We studied a cross-sectional sample of adult injection drug users (IDUs) in Kabul, Afghanistan, from June 2005 through June 2006. Study participants completed interviewer-administered questionnaires and underwent testing for HIV, antibody to HCV, and HBsAg. Overall prevalences of HIV, HCV, and HBsAg were 3.0% (95% confidence interval [CI] 1.7%–5.1%), 36.6% (95% CI 32.2%–41.0%), and 6.5% (95% CI 4.2%–8.7%), respectively (N = 464). Among male IDUs (n = 463), risky behavior, including sharing syringes (50.4%), paying women for sex (76.2%), and having sex with men or boys (28.3%), were common. Needle sharing, injecting for >3 years, and receiving injections from nonmedical providers were independently associated with increased risk for HCV infection. The high prevalence of risky behavior indicate that Kabul is at risk for an HIV epidemic. Scale-up of harm-reducing interventions is urgently needed.
机译:阿富汗的HIV,乙型肝炎表面抗原(HBsAg)和丙型肝炎病毒(HCV)流行率数据有限。我们研究了从2005年6月至2006年6月在阿富汗喀布尔的成年注射吸毒者(IDU)的横断面样本。研究参与者完成了由访调员管理的问卷调查,并对HIV,HCV抗体和HBsAg进行了测试。 HIV,HCV和HBsAg的总体患病率分别为3.0%(95%置信区间[CI] 1.7%–5.1%),36.6%(95%CI 32.2%–41.0%)和6.5%(95%CI 4.2%–分别为8.7%)(N = 464)。在男性注射毒品使用者中(n = 463),常见的危险行为包括共用注射器(50.4%),为女性付费(76.2%)以及与男性或男孩发生性行为(28.3%)。共用针头,注射> 3年以及从非医疗服务提供者那里注射针头与HCV感染风险增加独立相关。危险行为的高流行表明喀布尔有感染艾滋病毒的危险。迫切需要扩大减少危害的干预措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号